Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
Status:
Unknown status
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Rituximab, in the same doses as used in
rheumatoid arthritis patients, will benefit pemphigus patients. It also tests immune function
via the Cylex assay in pemphigus patients before and after treatment with RItuximab.